LEADER 01651nam  2200445   450 
001 9910717389103321
005 20221105095011.0
035   $a(CKB)4100000000883954
035   $a(NjHacI)994100000000883954
035   $a(OCoLC)1004963947
035   $a(EXLCZ)994100000000883954
100   $a20221105d2016      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNonpharmacologic treatments for menopause-associated vasomotor symptoms /$fKaren M. Goldstein [and eleven others]
210  1$aWashington, DC :$cDepartment of Veterans Affairs (US),$d[2016]
210  4$dİ2016
215   $a1 online resource (iv, 93 pages) $cillustrations
225 1 $aEvidence-based synthesis program
300   $a"July 2016."
320   $aIncludes bibliographical references.
410  0$aEvidence-based synthesis program (Series)
606   $aMenopause$xHormone therapy$zUnited States
615  0$aMenopause$xHormone therapy
676   $a618.175061
700   $aGoldstein$b Karen M.$01353976
702   $aCoeytaux$b Remy R.
702   $aWilliams$b John W.$cJr.,
712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service,
712 02$aDurham VA Medical Center.$bEvidence-based Synthesis Program Center.
712 02$aQuality Enhancement Research Initiative (U.S.)
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910717389103321
996   $aNonpharmacologic treatments for menopause-associated vasomotor symptoms$93342332
997   $aUNINA